Method for the treatment of angina

 

(57) Abstract:

The invention relates to medicine and for the treatment of angina. For this use the drug, which is an aqueous solution of trace elements in a qualitative and quantitative value ("Aspirin"), which is 3-5 times a day rinse the throat and is the inside of 20-25 ml. Specified monotherapy allows time 1-2 days to arrest the symptoms of the disease while improving immunity.

The invention relates to means for the treatment of widespread diseases - angina [1, 2].

Known drug for the treatment of angina [1, 2] in the form of sulfonamides and antibiotics. Their disadvantage is that they are all chemical substances that are foreign to the normal functioning of the human body and therefore often cause complications [1, 2].

Known also use for the treatment of angina various gargles of a throat in the form of solutions: aqueous solution of potassium permanganate aqueous solution of boric acid or sodium chloride, furatsilina and others [1, 2].

A common shortcoming of currently used drugs and rinse is Gcah for several weeks [1, 2], and can result in dangerous complications: rheumatism, arthritis, cholecystitis, nephritis, meningitis. This is especially dangerous due to the fact that the human body does not produce immunity against illness and disease can be repeated many times.

The purpose of the present invention is to create effective procedures for the treatment of angina by applying a known drug "Aspirin", previously used to prevent hair loss and General health [3-5] aqueous solution of salts of trace elements in the following concentrations, µg/g solution: copper 300-1000, zinc 50-100, indium 5-10, cobalt 3-5,manganese 10-50, chromium 0.05 to 0.1, silicon 2000-5000. Copper, zinc, indium, cobalt, manganese, chromium introduced in the form of chlorides, and silicon in the form of sodium silicate or potassium.

The objective is achieved due to the fact that for the treatment of angina drug "Aspirin" is used in the scheme: 3-5 times a day rinse this solution the throat in the course of disease and in the course of the disease and the week immediately after it through the day is the inside of 20-25 ml.

The essence of the invention lies in the fact that the ingestion containing in solution "Micin" trace elements make it possible to implement in humans numerous life the ability to improve immunity in the throat of a person locally and, in addition, due to the bactericidal action of the copper portion of pathogenic bacteria to destroy.

As a result, even complicated angina can be closed for 1-2 days and to avoid complications.

The advantage of the proposed method for the treatment of angina is that the human body receives only those substances and in approximately the same quantities necessary until a normal and active life. Therefore, complications from the use of the drug "Aspirin" fundamentally impossible.

As a result of application of a preparation "Aspirin" for the treatment of angina this disease will be harmless and even rare. Will disappear and called angina complications.

The economic effect from the use of the invention will be significant, but quantitatively it is currently difficult to estimate.

Sources of information

1. Reference practitioner, edited by A. Vorobyov, I. M.: Bayan, 1992, pp. 531-533.

2. Popular medical encyclopedia, edited by Pokrovsky C. I. M.: Soviet encyclopedia, 1991, pp. 24-25.

3. Cywinski S. C. Cosmetic remedy to stimulate hair growth on the head. RF patent 2012328, 1991.

the CSOs starvation, RF patent 2045952, 1992.

6. Moskalev Y. I. Mineral metabolism. M.: Medicine, 1985.

7. Podkolzin A. A., Dontsov Century. And. Immunity and trace elements. M: Alamanda, 1994.

Method for the treatment of angina by injection, characterized in that the quality of drug use aqueous solution of trace elements in the following concentrations, µg/g solution: copper - 300-1000, zinc - 50-100, indium - 5-10, cobalt - 3-5, manganese - 10-50, chrome - 0,05-0,1, silicon - 2000-5000, and copper, zinc, indium, cobalt, manganese, chromium is administered in the form of chlorides, silicon in the form of sodium silicate or potassium, which 3-5 times a day rinse a throat in the course of disease and to improve the overall immunity of the body in the course of disease and the week after it through the day is the inside of 20-25 ml of this solution.

 

Same patents:
The invention relates to pharmaceutical industry and relates to a method of obtaining injectable N,N1dibenzylethylenediamine salt of the penicillin (bicillin-1)

The invention relates to the field of medicine and relates to new organic complexes of cephalosporin antibiotics with dyes methylene blue or ethacridine lactate

The invention relates to medicine and can be used for local treatment of diabetes mellitus (DM) with purulent-necrotic complications of the foot and the high resistance of microorganisms to antibiotics

The invention relates to medicine, namely to surgery, and is intended for antibacterial protection anastomoses in the bowel resections

The invention relates to new derivatives of benzoxazinone General formula (I), where R1means N or carboxyethyl, R2represents hydrogen or alkyl, and R3is a different derivatively of amino acids, dipeptides and hydrazones acid groups, respectively, their conjugates with active substances, such as residues from a number of penicillin

The invention relates to pharmaceutical industry and relates to drugs used in obstetric practice for the treatment and prevention of infectious and inflammatory diseases and dysbacteriosis
The invention relates to medicine, specifically to a pharmaceutical composition having antimicrobial activity comprising as active principle an effective amount sulfalena and targeted supplements, which are used potato starch and/or corn, oxypropylation, magnesium stearate and/or calcium

The invention relates to new peptides of General formula 1 (H-a-Lys-d-Trp-Lys-c - Pro-d-Lys-Pro-Trp-e-Arg-NH2where a = -Ile or Lys; b= -Pro - or-Lys-; C, d = -Lys or Trp; e=Arg or Ala, having biocidal activity, which combine higher compared to indolizidines biocidal activity with no damaging effects on blood cells

The invention relates to a carbohydrate derivative of General formula I, where R1= H or CH2ОSO3-; R2and R3independently equal to N, (1-6C) alkyl or SO3-; R4= OSO3-; n= 0 or 1; p=1 or 2; or pharmaceutically acceptable salts

The invention relates to new derivatives of cephalosporin of the General formula I, in which R1denotes hydrogen or ester group, R2denotes a group of formula (IIA, IIb, IIC), Y denotes hydrogen, alkyl, substituted alkyl or acyl, R4denotes hydrogen, phenyl, cycloalkyl or alkyl, R5denotes hydrogen, phenyl, cycloalkyl, lower alkyl, saturated or unsaturated 5-6 membered heterocyclyl, optionally substituted alkyl, triptorelin, oxo or amino group, benzothiazolyl or a group of formula (IId, IIe, IIf), R7denotes alkyl, R8denotes hydrogen, cycloalkyl or alkyl, R9denotes hydrogen or alkyl, R10denotes hydrogen, alkyl, substituted alkyl, where the Deputy is selected from triptoreline, pyridyl, hydroxy, alkoxy, halogen, amino or sulfonic acid residue; hydroxy, amino, phenyl, alkenyl, cycloalkyl or a group of the formula-N=CH-Phe, where Phe denotes phenyl, substituted hydroxy, or R9and R10together with the nitrogen atom represent a saturated, unsaturated or substituted 5-6-membered heterocyclyl containing one or two nitrogen atom or oxygen, and the Deputy is selected from formyl or alkyl, etc
The invention relates to medicine, namely oncodermatology, medical cosmetology, pharmacology
The invention relates to medicine and can be used for treatment of influenza

The invention relates to medicine, specifically to medicines for the treatment of prostatitis and BPH

The invention relates to medicine, more specifically to dermatology, and can be used for the treatment of benign tumors (adenoma, fibroma), including viral etiology (all forms of warts, molluscum contagiosum), and precancerous diseases of the skin (keratosis, keratoacanthoma, cylindroma etc)
The invention relates to medicine, dermatology
The invention relates to medicine, namely to surgery, and is intended for the treatment of nonhealing wounds and trophic ulcers

The invention relates to the field of veterinary medicine, relates to a method of increasing the viability of young cattle and can be used for the prevention of non-communicable diseases and increase the integrity of the calves in the postnatal period

The invention relates to the development of burns and wound healing medicines and can be used in medical practice to disinfect and speed the healing of skin after thermal, chemical and radiation burns, and also for the treatment of wounds, cuts, frostbite and other skin lesions with concurrent analgesic effect
The invention relates to ophthalmology
The invention relates to medicine and can be used for treatment of influenza
Up!